Josiah Nieto, Garth Strohbehn, Daniel A. Goldstein, Alex Bryant. "Comparative effectiveness of pembrolizumab and nivolumab as first-line treatment for advanced/unresectable or metastatic melanoma: A propensity-score adjusted analysis from a US national health system.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e21513